| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.885 | 0.002 | 0.885 | Succinate dehydrogenase inhibitor | 0.638 0.002 CID_5282914 | ||
| 0.812 | 0.003 | 0.812 | Alcohol oxidase inhibitor | 0.764 0.003 CID_5282914 | ||
| 0.799 | 0.011 | 0.799 | Caspase 9 stimulant | 0.663 0.028 CID_5282914 | ||
| 0.79 | 0.004 | 0.79 | Platelet antagonist | 0.721 0.005 CID_5282914 | ||
| 0.735 | 0.003 | 0.78 | Alpha-N-acetylglucosaminidase inhibitor | 0.78 0.002 CID_5282914 | CID_5282914 | |
| 0.733 | 0.002 | 0.733 | GABA C receptor agonist | 0.592 0.003 CID_5282914 | ||
| 0.727 | 0.006 | 0.741 | Cholesterol antagonist | 0.741 0.005 CID_5282914 | CID_5282914 | |
| 0.718 | 0.007 | 0.727 | Aldehyde oxidase inhibitor | 0.727 0.006 CID_5282914 | CID_5282914 | |
| 0.7 | 0.002 | 0.7 | Porphobilinogen synthase inhibitor | 0.44 0.004 CID_5282914 | ||
| 0.671 | 0.008 | 0.702 | Vasodilator, peripheral | 0.702 0.006 CID_5282914 | CID_5282914 | |
| 0.661 | 0.006 | 0.661 | Histamine release inhibitor | 0.611 0.009 CID_5282914 | ||
| 0.662 | 0.009 | 0.71 | 5 Hydroxytryptamine release stimulant | 0.71 0.006 CID_5282914 | CID_5282914 | |
| 0.649 | 0.02 | 0.726 | Cyclophilin D inhibitor | 0.726 0.012 CID_5282914 | CID_5282914 | |
| 0.626 | 0.008 | 0.626 | 5 Hydroxytryptamine release inhibitor | 0.567 0.016 CID_5282914 | ||
| 0.607 | 0.003 | 0.607 | 5 Hydroxytryptamine uptake stimulant | 0.462 0.006 CID_5282914 | ||
| 0.61 | 0.009 | 0.61 | Apoptosis antagonist | 0.568 0.013 CID_5282914 | ||
| 0.611 | 0.015 | 0.675 | Antithrombotic | 0.675 0.009 CID_5282914 | CID_5282914 | |
| 0.59 | 0.005 | 0.59 | Anesthetic general | 0.531 0.006 CID_5282914 | ||
| 0.588 | 0.004 | 0.588 | Phospholipase C inhibitor | 0.497 0.006 CID_5282914 | ||
| 0.582 | 0.005 | 0.582 | Platelet aggregation inhibitor | 0.516 0.009 CID_5282914 | ||
| 0.586 | 0.009 | 0.586 | GABA C receptor rho-3 antagonist | 0.373 0.074 CID_5282914 | ||
| 0.579 | 0.003 | 0.579 | Tyrosine 3 hydroxylase inhibitor | 0.393 0.009 CID_5282914 | ||
| 0.574 | 0.002 | 0.574 | Ferrochelatase inhibitor | 0.439 0.003 CID_5282914 | ||
| 0.557 | 0.004 | 0.557 | Aldehyde dehydrogenase inhibitor | 0.53 0.004 CID_5282914 | ||
| 0.551 | 0.009 | 0.61 | Hypolipemic | 0.61 0.006 CID_5282914 | CID_5282914 | |
| 0.547 | 0.006 | 0.547 | Peroxidase inhibitor | 0.528 0.008 CID_5282914 | ||
| 0.55 | 0.009 | 0.55 | Superoxide dismutase inhibitor | 0.381 0.03 CID_5282914 | ||
| 0.541 | 0.002 | 0.554 | Glutamate decarboxylase inhibitor | 0.554 0.002 CID_5282914 | CID_5282914 | |
| 0.537 | 0.005 | 0.537 | Interleukin 2 agonist | 0.527 0.005 CID_5282914 | ||
| 0.579 | 0.059 | 0.665 | Antiinflammatory | 0.665 0.037 CID_5282914 | CID_5282914 | |
| 0.536 | 0.018 | 0.688 | Immunomodulator | 0.688 0.005 CID_5282914 | CID_5282914 | |
| 0.529 | 0.013 | 0.581 | Hypoglycemic | 0.581 0.009 CID_5282914 | CID_5282914 | |
| 0.519 | 0.005 | 0.519 | Growth hormone agonist | 0.482 0.007 CID_5282914 | ||
| 0.52 | 0.008 | 0.549 | Interleukin agonist | 0.549 0.006 CID_5282914 | CID_5282914 | |
| 0.514 | 0.003 | 0.557 | Glutamate dehydrogenase inhibitor | 0.557 0.003 CID_5282914 | CID_5282914 | |
| 0.533 | 0.025 | 0.557 | Immunosuppressant | 0.557 0.019 CID_5282914 | CID_5282914 | |
| 0.512 | 0.01 | 0.512 | Psychostimulant | 0.373 0.027 CID_5282914 | ||
| 0.504 | 0.002 | 0.545 | Triose-phosphate isomerase inhibitor | 0.545 0.002 CID_5282914 | CID_5282914 | |
| 0.501 | 0.012 | 0.501 | Angiogenesis stimulant | 0.363 0.029 CID_5282914 | ||
| 0.478 | 0.001 | 0.527 | Aconitate hydratase inhibitor | 0.527 0.001 CID_5282914 | CID_5282914 | |
| 0.457 | 0.003 | 0.506 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.506 0.002 CID_5282914 | CID_5282914 | |
| 0.487 | 0.034 | 0.487 | Toll-Like receptor agonist | 0.391 0.064 CID_5282914 | ||
| 0.454 | 0.003 | 0.487 | Carbamoyl phosphate synthetase inhibitor | 0.487 0.002 CID_5282914 | CID_5282914 | |
| 0.45 | 0.005 | 0.687 | Insulin secretagoues | 0.687 0.003 CID_5282914 | CID_5282914 | |
| 0.447 | 0.003 | 0.447 | Phosphofructokinase-1 inhibitor | 0.428 0.003 CID_5282914 | ||
| 0.45 | 0.007 | 0.45 | Sodium/bile acid cotransporter inhibitor | 0.411 0.014 CID_5282914 | ||
| 0.465 | 0.023 | 0.635 | Interleukin antagonist | 0.635 0.009 CID_5282914 | CID_5282914 | |
| 0.445 | 0.003 | 0.445 | Catalase inhibitor | 0.425 0.003 CID_5282914 | ||
| 0.44 | 0.002 | 0.44 | Adenylate kinase inhibitor | 0.413 0.003 CID_5282914 | ||
| 0.435 | 0.002 | 0.523 | Fumarate hydratase inhibitor | 0.523 0.002 CID_5282914 | CID_5282914 | |
| 0.432 | 0.004 | 0.432 | Gastrin inhibitor | 0.362 0.008 CID_5282914 | ||
| 0.453 | 0.036 | 0.52 | Immunostimulant | 0.52 0.026 CID_5282914 | CID_5282914 | |
| 0.423 | 0.007 | 0.423 | Protein kinase stimulant | 0.36 0.011 CID_5282914 | ||
| 0.421 | 0.009 | 0.421 | Thrombolytic | 0.351 0.017 CID_5282914 | ||
| 0.416 | 0.005 | 0.416 | Cell adhesion inhibitor | 0.255 0.014 CID_5282914 | ||
| 0.424 | 0.019 | 0.424 | DNA synthesis inhibitor | 0.402 0.021 CID_5282914 | ||
| 0.424 | 0.019 | 0.545 | Vasodilator | 0.545 0.009 CID_5282914 | CID_5282914 | |
| 0.408 | 0.004 | 0.408 | Alcohol dehydrogenase inhibitor | 0.357 0.004 CID_5282914 | ||
| 0.403 | 0.003 | 0.403 | Photosensitizer | 0.217 0.01 CID_5282914 | ||
| 0.398 | 0.004 | 0.467 | Prostaglandin EP2 antagonist | 0.467 0.003 CID_5282914 | CID_5282914 | |
| 0.393 | 0.009 | 0.393 | Lipocortins synthesis antagonist | 0.299 0.021 CID_5282914 | ||
| 0.39 | 0.006 | 0.39 | DNA polymerase I inhibitor | 0.23 0.02 CID_5282914 | ||
| 0.385 | 0.005 | 0.385 | Phospholipase A2 inhibitor | 0.309 0.012 CID_5282914 | ||
| 0.393 | 0.014 | 0.447 | Non-steroidal antiinflammatory agent | 0.447 0.009 CID_5282914 | CID_5282914 | |
| 0.378 | 0.004 | 0.378 | Prostaglandin antagonist | 0.305 0.005 CID_5282914 | ||
| 0.381 | 0.007 | 0.381 | Insulin sensitizer | 0.369 0.008 CID_5282914 | ||
| 0.423 | 0.051 | 0.423 | Toll-Like receptor 7 agonist | 0.33 0.093 CID_5282914 | ||
| 0.373 | 0.004 | 0.373 | GABA C receptor antagonist | 0.23 0.008 CID_5282914 | ||
| 0.375 | 0.015 | 0.375 | Platelet adhesion inhibitor | 0.279 0.04 CID_5282914 | ||
| 0.384 | 0.025 | 0.384 | Insulysin inhibitor | 0.338 0.039 CID_5282914 | ||
| 0.396 | 0.037 | 0.418 | Vasodilator, coronary | 0.418 0.03 CID_5282914 | CID_5282914 | |
| 0.361 | 0.003 | 0.361 | Argininosuccinate synthase inhibitor | 0.229 0.006 CID_5282914 | ||
| 0.394 | 0.041 | 0.502 | Spasmolytic | 0.502 0.023 CID_5282914 | CID_5282914 | |
| 0.362 | 0.012 | 0.362 | Bone formation stimulant | 0.317 0.015 CID_5282914 | ||
| 0.362 | 0.013 | 0.43 | Interferon gamma antagonist | 0.43 0.009 CID_5282914 | CID_5282914 | |
| 0.369 | 0.022 | 0.369 | RNA-directed DNA polymerase inhibitor | 0.289 0.034 CID_5282914 | ||
| 0.402 | 0.063 | 0.402 | Transcription factor NF kappa B inhibitor | 0.315 0.087 CID_5282914 | ||
| 0.349 | 0.013 | 0.349 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.287 0.028 CID_5282914 | ||
| 0.333 | 0.002 | 0.333 | Glutamate (mGluR6) antagonist | 0.16 0.003 CID_5282914 | ||
| 0.33 | 0.003 | 0.33 | Sphingosine 1-phosphate receptor 5 agonist | 0.215 0.004 CID_5282914 | ||
| 0.365 | 0.041 | 0.365 | Calcium channel activator | 0.345 0.054 CID_5282914 | ||
| 0.4 | 0.077 | 0.449 | Antibacterial | 0.449 0.057 CID_5282914 | CID_5282914 | |
| 0.323 | 0.005 | 0.323 | Catenin beta inhibitor | 0.24 0.013 CID_5282914 | ||
| 0.321 | 0.004 | 0.321 | Toll-Like receptor 2 antagonist | 0.312 0.004 CID_5282914 | ||
| 0.322 | 0.005 | 0.322 | Cell adhesion molecule inhibitor | 0.172 0.012 CID_5282914 | ||
| 0.359 | 0.048 | 0.359 | Lipoxygenase inhibitor | 0.236 0.109 CID_5282914 | ||
| 0.313 | 0.004 | 0.313 | Electrolyte absorption antagonist | 0.209 0.007 CID_5282914 | ||
| 0.333 | 0.023 | 0.333 | Dual specificity phosphatase inhibitor | 0.152 0.092 CID_5282914 | ||
| 0.324 | 0.015 | 0.324 | Protein-tyrosine phosphatase inhibitor | 0.242 0.033 CID_5282914 | ||
| 0.318 | 0.01 | 0.318 | Cholesterol synthesis inhibitor | 0.306 0.011 CID_5282914 | ||
| 0.354 | 0.045 | 0.378 | Antioxidant | 0.378 0.039 CID_5282914 | CID_5282914 | |
| 0.414 | 0.107 | 0.414 | Apoptosis agonist | 0.384 0.122 CID_5282914 | ||
| 0.309 | 0.003 | 0.309 | Prolactin inhibitor | 0.207 0.008 CID_5282914 | ||
| 0.307 | 0.005 | 0.307 | Peroxisome proliferator-activated receptor gamma agonist | 0.256 0.005 CID_5282914 | ||
| 0.303 | 0.004 | 0.303 | Creatine kinase inhibitor | 0.162 0.019 CID_5282914 | ||
| 0.399 | 0.102 | 0.399 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.308 0.202 CID_5282914 | ||
| 0.311 | 0.015 | 0.311 | Neurotrophic factor enhancer | 0.251 0.038 CID_5282914 | ||
| 0.295 | 0.004 | 0.295 | Ornithine carbamoyltransferase inhibitor | 0.206 0.007 CID_5282914 | ||
| 0.324 | 0.033 | 0.418 | Cyclic AMP phosphodiesterase inhibitor | 0.418 0.014 CID_5282914 | CID_5282914 | |
| 0.312 | 0.022 | 0.312 | DNA methyltransferase I inhibitor | 0.311 0.023 CID_5282914 | ||
| 0.31 | 0.021 | 0.31 | Diuretic | 0.223 0.036 CID_5282914 | ||
| 0.334 | 0.046 | 0.334 | DNA damaging | 0.271 0.07 CID_5282914 | ||
| 0.288 | 0.004 | 0.288 | GABA C receptor rho-1 antagonist | 0.207 0.007 CID_5282914 | ||
| 0.288 | 0.003 | 0.296 | Biliverdin reductase inhibitor | 0.296 0.003 CID_5282914 | CID_5282914 | |
| 0.309 | 0.027 | 0.366 | Hepatoprotectant | 0.366 0.017 CID_5282914 | CID_5282914 | |
| 0.302 | 0.022 | 0.302 | Melanin inhibitor | 0.289 0.023 CID_5282914 | ||
| 0.296 | 0.019 | 0.439 | Amylase inhibitor | 0.439 0.008 CID_5282914 | CID_5282914 | |
| 0.286 | 0.009 | 0.286 | Aminopeptidase B inhibitor | 0.264 0.011 CID_5282914 | ||
| 0.278 | 0.004 | 0.278 | Folate antagonist | 0.223 0.007 CID_5282914 | ||
| 0.277 | 0.004 | 0.277 | GABA aminotransferase inhibitor | 0.159 0.006 CID_5282914 | ||
| 0.279 | 0.007 | 0.279 | Carbonic anhydrase III inhibitor | 0.164 0.024 CID_5282914 | ||
| 0.273 | 0.003 | 0.273 | Adenylate cyclase stimulant | 0.264 0.004 CID_5282914 | ||
| 0.277 | 0.01 | 0.478 | Expectorant | 0.478 0.004 CID_5282914 | CID_5282914 | |
| 0.269 | 0.003 | 0.269 | Arachidonic acid antagonist | 0.244 0.007 CID_5282914 | ||
| 0.295 | 0.03 | 0.295 | Dual specificity phosphatase 3 inhibitor | 0.151 0.096 CID_5282914 | ||
| 0.275 | 0.012 | 0.275 | Cell wall synthesis inhibitor | 0.242 0.018 CID_5282914 | ||
| 0.293 | 0.03 | 0.314 | DNA methylase inhibitor | 0.314 0.024 CID_5282914 | CID_5282914 | |
| 0.265 | 0.003 | 0.265 | Sphingosine 1-phosphate receptor 4 agonist | 0.188 0.005 CID_5282914 | ||
| 0.266 | 0.004 | 0.266 | Sphingosine 1-phosphate receptor 2 antagonist | 0.179 0.015 CID_5282914 | ||
| 0.273 | 0.012 | 0.273 | Cystathionine beta-synthase inhibitor | 0.198 0.025 CID_5282914 | ||
| 0.265 | 0.004 | 0.383 | Phenylalanine 4-hydroxylase inhibitor | 0.383 0.003 CID_5282914 | CID_5282914 | |
| 0.262 | 0.003 | 0.262 | Glycine receptor agonist | 0.167 0.005 CID_5282914 | ||
| 0.263 | 0.005 | 0.263 | Integrin antagonist | 0.075 0.021 CID_5282914 | ||
| 0.262 | 0.005 | 0.262 | Vanilloid 1 agonist | 0.208 0.01 CID_5282914 | ||
| 0.258 | 0.003 | 0.258 | Acyl-CoA dehydrogenase inhibitor | 0.257 0.003 CID_5282914 | ||
| 0.259 | 0.004 | 0.259 | Plasminogen activator inhibitor antagonist | 0.134 0.005 CID_5282914 | ||
| 0.254 | 0.003 | 0.254 | Lysophosphatidic acid 2 receptor antagonist | 0.098 0.004 CID_5282914 | ||
| 0.268 | 0.018 | 0.268 | Neurotensin receptor agonist | 0.185 0.045 CID_5282914 | ||
| 0.254 | 0.004 | 0.254 | Interferon agonist | 0.244 0.004 CID_5282914 | ||
| 0.251 | 0.004 | 0.251 | Ornithine decarboxylase inhibitor | 0.165 0.008 CID_5282914 | ||
| 0.268 | 0.024 | 0.338 | Lipid peroxidase inhibitor | 0.338 0.014 CID_5282914 | CID_5282914 | |
| 0.25 | 0.006 | 0.284 | Mucolytic | 0.284 0.005 CID_5282914 | CID_5282914 | |
| 0.255 | 0.011 | 0.255 | GABA C receptor rho-2 antagonist | 0.15 0.074 CID_5282914 | ||
| 0.252 | 0.009 | 0.257 | Histidine decarboxylase inhibitor | 0.257 0.008 CID_5282914 | CID_5282914 | |
| 0.246 | 0.005 | 0.246 | TRPA1 agonist | 0.204 0.01 CID_5282914 | ||
| 0.254 | 0.013 | 0.254 | Interleukin 4 antagonist | 0.183 0.028 CID_5282914 | ||
| 0.294 | 0.053 | 0.294 | Free radical scavenger | 0.27 0.06 CID_5282914 | ||
| 0.242 | 0.001 | 0.242 | Glucose-6-phosphate isomerase inhibitor | 0.229 0.001 CID_5282914 | ||
| 0.244 | 0.004 | 0.244 | NMDA receptor agonist | 0.139 0.009 CID_5282914 | ||
| 0.254 | 0.016 | 0.254 | Protein-tyrosine phosphatase 1B inhibitor | 0.202 0.029 CID_5282914 | ||
| 0.24 | 0.003 | 0.339 | Prostaglandin F2 alpha antagonist | 0.339 0.003 CID_5282914 | CID_5282914 | |
| 0.238 | 0.002 | 0.238 | Ca2+-transporting ATPase inhibitor | 0.2 0.004 CID_5282914 | ||
| 0.257 | 0.022 | 0.257 | Interleukin 6 antagonist | 0.244 0.024 CID_5282914 | ||
| 0.249 | 0.017 | 0.323 | Alkylator | 0.323 0.011 CID_5282914 | CID_5282914 | |
| 0.235 | 0.004 | 0.235 | Sphingosine 1-phosphate receptor 5 antagonist | 0.172 0.032 CID_5282914 | ||
| 0.274 | 0.048 | 0.274 | Anticonvulsant | |||
| 0.24 | 0.013 | 0.24 | Cathepsin G inhibitor | 0.165 0.019 CID_5282914 | ||
| 0.249 | 0.024 | 0.249 | Monophenol monooxygenase inhibitor | 0.248 0.024 CID_5282914 | ||
| 0.228 | 0.005 | 0.228 | Sphingosine 1-phosphate receptor 4 antagonist | 0.154 0.03 CID_5282914 | ||
| 0.228 | 0.006 | 0.228 | Thioredoxin inhibitor | 0.097 0.052 CID_5282914 | ||
| 0.231 | 0.011 | 0.231 | Mediator release inhibitor | 0.168 0.022 CID_5282914 | ||
| 0.244 | 0.026 | 0.244 | Antipruritic | 0.189 0.057 CID_5282914 | ||
| 0.225 | 0.009 | 0.241 | NADH dehydrogenase inhibitor | 0.241 0.008 CID_5282914 | CID_5282914 | |
| 0.23 | 0.016 | 0.23 | Cathepsin H inhibitor | 0.207 0.021 CID_5282914 | ||
| 0.259 | 0.045 | 0.278 | Peptidyltransferase inhibitor | 0.278 0.034 CID_5282914 | CID_5282914 | |
| 0.225 | 0.012 | 0.225 | Cyclooxygenase 3 inhibitor | 0.194 0.021 CID_5282914 | ||
| 0.227 | 0.015 | 0.245 | UDP-glucose 4-epimerase inhibitor | 0.245 0.014 CID_5282914 | CID_5282914 | |
| 0.215 | 0.003 | 0.215 | GABA B receptor agonist | 0.16 0.004 CID_5282914 | ||
| 0.216 | 0.005 | 0.216 | Leukotriene synthesis inhibitor | 0.139 0.011 CID_5282914 | ||
| 0.258 | 0.049 | 0.258 | Neuropeptide Y2 antagonist | 0.239 0.067 CID_5282914 | ||
| 0.215 | 0.007 | 0.215 | Caspase 3 inhibitor | 0.192 0.011 CID_5282914 | ||
| 0.215 | 0.007 | 0.215 | Keratolytic | 0.151 0.014 CID_5282914 | ||
| 0.232 | 0.024 | 0.241 | Hemostatic | 0.241 0.023 CID_5282914 | CID_5282914 | |
| 0.245 | 0.04 | 0.245 | Anticoagulant | 0.169 0.067 CID_5282914 | ||
| 0.209 | 0.006 | 0.227 | Aminopeptidase I inhibitor | 0.227 0.005 CID_5282914 | CID_5282914 | |
| 0.297 | 0.095 | 0.297 | Thyroid hormone antagonist | |||
| 0.206 | 0.003 | 0.206 | Glutamate (mGluR3) antagonist | 0.075 0.005 CID_5282914 | ||
| 0.221 | 0.021 | 0.221 | Chelator | 0.115 0.058 CID_5282914 | ||
| 0.207 | 0.006 | 0.207 | CDC25A inhibitor | 0.123 0.018 CID_5282914 | ||
| 0.207 | 0.007 | 0.21 | Toll-Like receptor 2 agonist | 0.21 0.006 CID_5282914 | CID_5282914 | |
| 0.217 | 0.017 | 0.217 | Farnesoid X receptor antagonist | 0.134 0.075 CID_5282914 | ||
| 0.317 | 0.12 | 0.317 | 15-Lipoxygenase inhibitor | |||
| 0.202 | 0.005 | 0.202 | Glutathione S-transferase inhibitor | 0.147 0.013 CID_5282914 | ||
| 0.197 | 0.003 | 0.322 | Prostaglandin agonist | 0.322 0.002 CID_5282914 | CID_5282914 | |
| 0.2 | 0.007 | 0.2 | Vanilloid agonist | 0.123 0.017 CID_5282914 | ||
| 0.204 | 0.011 | 0.204 | Selectin antagonist | 0.173 0.014 CID_5282914 | ||
| 0.196 | 0.004 | 0.196 | Glycine receptor antagonist | 0.129 0.014 CID_5282914 | ||
| 0.198 | 0.006 | 0.198 | Leukotriene antagonist | 0.189 0.006 CID_5282914 | ||
| 0.195 | 0.005 | 0.195 | Glutamate release inhibitor | 0.183 0.005 CID_5282914 | ||
| 0.197 | 0.007 | 0.197 | GP IIb/IIIa receptor antagonist | 0.087 0.02 CID_5282914 | ||
| 0.214 | 0.027 | 0.225 | ATPase inhibitor | 0.225 0.022 CID_5282914 | CID_5282914 | |
| 0.209 | 0.023 | 0.209 | 5-Lipoxygenase inhibitor | |||
| 0.195 | 0.01 | 0.195 | Hematopoietic | 0.193 0.01 CID_5282914 | ||
| 0.191 | 0.008 | 0.197 | Toll-Like receptor 4 antagonist | 0.197 0.007 CID_5282914 | CID_5282914 | |
| 0.196 | 0.014 | 0.196 | Interleukin 8 antagonist | 0.126 0.055 CID_5282914 | ||
| 0.23 | 0.049 | 0.259 | Nitric-oxide synthase stimulant | 0.259 0.027 CID_5282914 | CID_5282914 | |
| 0.193 | 0.013 | 0.193 | HIV-1 integrase (Overall Integration) inhibitor | 0.111 0.046 CID_5282914 | ||
| 0.194 | 0.014 | 0.194 | Carbonic anhydrase VI inhibitor | 0.097 0.041 CID_5282914 | ||
| 0.187 | 0.008 | 0.187 | Interleukin 1 beta converting enzyme inhibitor | 0.137 0.024 CID_5282914 | ||
| 0.187 | 0.009 | 0.187 | Heat shock protein 70 antagonist | 0.158 0.03 CID_5282914 | ||
| 0.271 | 0.095 | 0.271 | Caspase 3 stimulant | 0.251 0.112 CID_5282914 | ||
| 0.182 | 0.006 | 0.182 | Glycine transporter 2 inhibitor | 0.049 0.031 CID_5282914 | ||
| 0.182 | 0.007 | 0.182 | Anabolic | 0.171 0.009 CID_5282914 | ||
| 0.201 | 0.025 | 0.267 | Adenylate cyclase inhibitor | 0.267 0.017 CID_5282914 | CID_5282914 | |
| 0.184 | 0.009 | 0.184 | DOPA decarboxylase inhibitor | 0.139 0.028 CID_5282914 | ||
| 0.179 | 0.005 | 0.179 | Lanosterol 14 alpha demethylase inhibitor | 0.143 0.014 CID_5282914 | ||
| 0.202 | 0.029 | 0.202 | Histone deacetylase SIRT1 inhibitor | 0.146 0.065 CID_5282914 | ||
| 0.177 | 0.004 | 0.177 | Purinergic P2Y12 antagonist | 0.082 0.005 CID_5282914 | ||
| 0.208 | 0.036 | 0.208 | Thiol protease inhibitor | 0.165 0.057 CID_5282914 | ||
| 0.187 | 0.016 | 0.187 | Carbonic anhydrase XIII inhibitor | 0.116 0.031 CID_5282914 | ||
| 0.242 | 0.073 | 0.242 | Calpain inhibitor | |||
| 0.171 | 0.002 | 0.171 | Lysophosphatidic acid 3 receptor antagonist | 0.131 0.003 CID_5282914 | ||
| 0.168 | 0.004 | 0.168 | AMPA 4 receptor antagonist | 0.043 0.022 CID_5282914 | ||
| 0.166 | 0.003 | 0.18 | ATP citrate lysase inhibitor | 0.18 0.002 CID_5282914 | CID_5282914 | |
| 0.194 | 0.03 | 0.204 | Neurotrophic factor | 0.204 0.026 CID_5282914 | CID_5282914 | |
| 0.166 | 0.004 | 0.2 | Mannosidase inhibitor | 0.2 0.003 CID_5282914 | CID_5282914 | |
| 0.177 | 0.015 | 0.177 | Sphingomyelinase inhibitor | 0.155 0.022 CID_5282914 | ||
| 0.185 | 0.024 | 0.22 | Microtubule formation inhibitor | 0.22 0.016 CID_5282914 | CID_5282914 | |
| 0.166 | 0.005 | 0.166 | Bile acid receptor antagonist | 0.127 0.015 CID_5282914 | ||
| 0.267 | 0.107 | 0.267 | Thyroid hormone beta antagonist | |||
| 0.26 | 0.103 | 0.26 | 12-Lipoxygenase inhibitor | |||
| 0.161 | 0.004 | 0.161 | Interferon inducer | 0.152 0.004 CID_5282914 | ||
| 0.162 | 0.005 | 0.162 | Sphingosine 1-phosphate receptor antagonist | 0.104 0.019 CID_5282914 | ||
| 0.169 | 0.013 | 0.195 | Electron transport complex I inhibitor | 0.195 0.009 CID_5282914 | CID_5282914 | |
| 0.18 | 0.024 | 0.18 | Nav1.4 sodium channel blocker | 0.12 0.052 CID_5282914 | ||
| 0.16 | 0.004 | 0.16 | Thromboxane synthase inhibitor | 0.121 0.005 CID_5282914 | ||
| 0.159 | 0.004 | 0.159 | Leukotriene D4 antagonist | 0.101 0.006 CID_5282914 | ||
| 0.281 | 0.127 | 0.281 | Calpain 2 inhibitor | |||
| 0.157 | 0.005 | 0.157 | Leukotriene B4 antagonist | 0.143 0.005 CID_5282914 | ||
| 0.154 | 0.004 | 0.154 | Sphingosine 1-phosphate receptor 1 antagonist | 0.103 0.009 CID_5282914 | ||
| 0.163 | 0.014 | 0.163 | ABCA1 expression enhancer | 0.12 0.031 CID_5282914 | ||
| 0.153 | 0.004 | 0.153 | Thromboxane antagonist | 0.134 0.005 CID_5282914 | ||
| 0.16 | 0.011 | 0.16 | Antimetabolite | 0.11 0.015 CID_5282914 | ||
| 0.167 | 0.02 | 0.167 | Gastric antisecretory | 0.135 0.034 CID_5282914 | ||
| 0.158 | 0.01 | 0.158 | Carbonic anhydrase stimulant | 0.079 0.026 CID_5282914 | ||
| 0.152 | 0.005 | 0.152 | Peroxisome proliferator-activated receptor delta antagonist | 0.092 0.006 CID_5282914 | ||
| 0.175 | 0.03 | 0.175 | Antibacterial (Helicobacter pylori) | 0.175 0.03 CID_5282914 | ||
| 0.151 | 0.007 | 0.151 | Purinergic P2X1 antagonist | 0.112 0.013 CID_5282914 | ||
| 0.181 | 0.037 | 0.224 | Anesthetic local | 0.224 0.026 CID_5282914 | CID_5282914 | |
| 0.147 | 0.003 | 0.147 | Leukotriene B4 receptor 1 antagonist | 0.096 0.004 CID_5282914 | ||
| 0.15 | 0.006 | 0.15 | CDC25B inhibitor | |||
| 0.147 | 0.004 | 0.147 | Prostaglandin D2 antagonist | 0.063 0.005 CID_5282914 | ||
| 0.147 | 0.006 | 0.147 | Peroxisome proliferator-activated receptor alpha agonist | 0.129 0.008 CID_5282914 | ||
| 0.161 | 0.02 | 0.161 | Uric acid excretion stimulant | |||
| 0.178 | 0.038 | 0.178 | CF transmembrane conductance regulator agonist | 0.14 0.095 CID_5282914 | ||
| 0.144 | 0.003 | 0.268 | Prostaglandin E2 agonist | 0.268 0.002 CID_5282914 | CID_5282914 | |
| 0.143 | 0.004 | 0.143 | Phospholipase D inhibitor | 0.109 0.01 CID_5282914 | ||
| 0.17 | 0.031 | 0.17 | Histone deacetylase class III inhibitor | |||
| 0.141 | 0.002 | 0.141 | Membrane dipeptidase inhibitor | 0.105 0.003 CID_5282914 | ||
| 0.145 | 0.007 | 0.145 | 5-Alpha-reductase inhibitor | 0.051 0.018 CID_5282914 | ||
| 0.142 | 0.004 | 0.142 | Alpha-mannosidase inhibitor | 0.132 0.004 CID_5282914 | ||
| 0.141 | 0.004 | 0.141 | Vanilloid 4 agonist | 0.123 0.006 CID_5282914 | ||
| 0.141 | 0.004 | 0.141 | Thromboxane A2 antagonist | 0.118 0.005 CID_5282914 | ||
| 0.152 | 0.015 | 0.152 | Transcription factor NF kappa B stimulant | 0.142 0.018 CID_5282914 | ||
| 0.166 | 0.03 | 0.166 | Pregnane X receptor agonist | 0.13 0.1 CID_5282914 | ||
| 0.141 | 0.005 | 0.141 | Cholecystokinin B agonist | 0.042 0.021 CID_5282914 | ||
| 0.233 | 0.098 | 0.253 | Transcription factor STAT3 inhibitor | 0.253 0.081 CID_5282914 | CID_5282914 | |
| 0.141 | 0.007 | 0.141 | Caspase 9 inhibitor | 0.1 0.014 CID_5282914 | ||
| 0.137 | 0.003 | 0.206 | Prostacyclin agonist | 0.206 0.002 CID_5282914 | CID_5282914 | |
| 0.138 | 0.005 | 0.138 | Purinergic P2Y antagonist | 0.11 0.008 CID_5282914 | ||
| 0.146 | 0.014 | 0.237 | Interleukin 12 antagonist | 0.237 0.005 CID_5282914 | CID_5282914 | |
| 0.181 | 0.048 | 0.186 | Hexokinase inhibitor | 0.186 0.044 CID_5282914 | CID_5282914 | |
| 0.137 | 0.005 | 0.137 | Estrogen-related receptor beta agonist | 0.106 0.018 CID_5282914 | ||
| 0.149 | 0.017 | 0.149 | Acetylcholine release stimulant | 0.107 0.072 CID_5282914 | ||
| 0.134 | 0.004 | 0.134 | Kainate receptor 2 antagonist | 0.037 0.024 CID_5282914 | ||
| 0.133 | 0.003 | 0.133 | Glutamate (mGluR1a) agonist | 0.032 0.008 CID_5282914 | ||
| 0.175 | 0.046 | 0.178 | Mannose-6-phosphate isomerase inhibitor | 0.178 0.044 CID_5282914 | CID_5282914 | |
| 0.16 | 0.031 | 0.16 | Xanthine oxidase inhibitor | 0.157 0.032 CID_5282914 | ||
| 0.133 | 0.004 | 0.133 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.058 0.006 CID_5282914 | ||
| 0.137 | 0.009 | 0.137 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.11 0.014 CID_5282914 | ||
| 0.132 | 0.004 | 0.132 | Sphingosine 1-phosphate receptor agonist | 0.129 0.004 CID_5282914 | ||
| 0.136 | 0.009 | 0.136 | Granulocyte macrophage colony stimulating factor agonist | 0.094 0.044 CID_5282914 | ||
| 0.128 | 0.003 | 0.151 | Prostaglandin EP4 agonist | 0.151 0.002 CID_5282914 | CID_5282914 | |
| 0.128 | 0.002 | 0.128 | Kainate receptor agonist | 0.076 0.004 CID_5282914 | ||
| 0.151 | 0.028 | 0.153 | AMP-activated protein kinase stimulant | 0.153 0.027 CID_5282914 | CID_5282914 | |
| 0.214 | 0.091 | 0.214 | Antiamyloidogenic | 0.166 0.127 CID_5282914 | ||
| 0.127 | 0.004 | 0.127 | Prostacyclin antagonist | 0.115 0.004 CID_5282914 | ||
| 0.127 | 0.005 | 0.127 | Sphingosine 1-phosphate receptor 3 antagonist | 0.084 0.014 CID_5282914 | ||
| 0.128 | 0.007 | 0.128 | NMDA receptor glycine site agonist | 0.082 0.027 CID_5282914 | ||
| 0.126 | 0.004 | 0.126 | Glutamate (mGluR7) antagonist | 0.086 0.021 CID_5282914 | ||
| 0.126 | 0.004 | 0.126 | Glutamate (mGluR4) antagonist | 0.047 0.024 CID_5282914 | ||
| 0.125 | 0.005 | 0.125 | Kainate receptor antagonist | |||
| 0.123 | 0.003 | 0.123 | Leukotriene C antagonist | 0.098 0.004 CID_5282914 | ||
| 0.127 | 0.008 | 0.127 | NMDA receptor subunit 3B antagonist | |||
| 0.133 | 0.014 | 0.133 | Ribonucleoside-diphosphate reductase inhibitor | 0.13 0.014 CID_5282914 | ||
| 0.122 | 0.003 | 0.122 | Glutamate (mGluR1) agonist | 0.041 0.005 CID_5282914 | ||
| 0.125 | 0.007 | 0.125 | CD45 antagonist | 0.073 0.014 CID_5282914 | ||
| 0.128 | 0.01 | 0.128 | Elastase 1 inhibitor | 0.082 0.034 CID_5282914 | ||
| 0.122 | 0.004 | 0.122 | Retinoid X alpha receptor agonist | 0.06 0.011 CID_5282914 | ||
| 0.118 | 0.003 | 0.118 | Calcium-dependent phospholipase A2 inhibitor | 0.028 0.004 CID_5282914 | ||
| 0.119 | 0.004 | 0.119 | Free fatty acid receptor 1 agonist | 0.097 0.004 CID_5282914 | ||
| 0.118 | 0.002 | 0.118 | Glutamate (mGluR8) agonist | 0.085 0.004 CID_5282914 | ||
| 0.13 | 0.015 | 0.13 | Ribonucleotide reductase inhibitor | 0.128 0.015 CID_5282914 | ||
| 0.123 | 0.009 | 0.128 | Peroxisome proliferator-activated receptor gamma antagonist | 0.128 0.009 CID_5282914 | CID_5282914 | |
| 0.118 | 0.005 | 0.157 | Prostaglandin EP3 antagonist | 0.157 0.004 CID_5282914 | CID_5282914 | |
| 0.118 | 0.005 | 0.118 | Leukotriene A4 hydrolase inhibitor | 0.073 0.01 CID_5282914 | ||
| 0.117 | 0.005 | 0.117 | 5-Alpha-reductase 2 inhibitor | 0.02 0.013 CID_5282914 | ||
| 0.117 | 0.005 | 0.117 | Glutamate (mGluR group III) antagonist | 0.047 0.024 CID_5282914 | ||
| 0.119 | 0.007 | 0.119 | Macrophage elastase inhibitor | 0.095 0.01 CID_5282914 | ||
| 0.115 | 0.004 | 0.144 | Prostaglandin EP4 antagonist | 0.144 0.004 CID_5282914 | CID_5282914 | |
| 0.121 | 0.011 | 0.141 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.141 0.009 CID_5282914 | CID_5282914 | |
| 0.184 | 0.074 | 0.255 | Nitric oxide antagonist | 0.255 0.05 CID_5282914 | CID_5282914 | |
| 0.154 | 0.044 | 0.154 | Proteasome inhibitor | 0.143 0.051 CID_5282914 | ||
| 0.114 | 0.004 | 0.119 | Sphingosine 1-phosphate receptor 1 agonist | 0.119 0.004 CID_5282914 | CID_5282914 | |
| 0.11 | 0.001 | 0.11 | Carbonic anhydrase X inhibitor | 0.079 0.002 CID_5282914 | ||
| 0.11 | 0.001 | 0.11 | Carbonic anhydrase VIII inhibitor | 0.079 0.002 CID_5282914 | ||
| 0.112 | 0.003 | 0.112 | Arginase inhibitor | 0.099 0.004 CID_5282914 | ||
| 0.13 | 0.022 | 0.13 | Glutamate (mGluR7) agonist | 0.102 0.056 CID_5282914 | ||
| 0.112 | 0.005 | 0.117 | MDM2 inhibitor | 0.117 0.004 CID_5282914 | CID_5282914 | |
| 0.12 | 0.012 | 0.12 | Carbonic anhydrase VB inhibitor | 0.062 0.034 CID_5282914 | ||
| 0.111 | 0.004 | 0.111 | Retinoid X receptor agonist | 0.078 0.008 CID_5282914 | ||
| 0.118 | 0.011 | 0.118 | NMDA 2C receptor antagonist | 0.064 0.04 CID_5282914 | ||
| 0.219 | 0.113 | 0.313 | Transcription factor STAT inhibitor | 0.313 0.049 CID_5282914 | CID_5282914 | |
| 0.117 | 0.012 | 0.119 | Prostaglandin E2 antagonist | 0.119 0.012 CID_5282914 | CID_5282914 | |
| 0.144 | 0.039 | 0.144 | Falcipain 3 inhibitor | |||
| 0.124 | 0.02 | 0.124 | Carbonic anhydrase V inhibitor | |||
| 0.108 | 0.004 | 0.108 | Glucagon receptor antagonist | 0.064 0.007 CID_5282914 | ||
| 0.106 | 0.003 | 0.169 | Prostaglandin EP2 agonist | 0.169 0.002 CID_5282914 | CID_5282914 | |
| 0.143 | 0.04 | 0.143 | GABA receptor agonist | |||
| 0.106 | 0.003 | 0.106 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.052 0.004 CID_5282914 | ||
| 0.131 | 0.029 | 0.131 | Calcium antagonist | 0.117 0.037 CID_5282914 | ||
| 0.117 | 0.016 | 0.117 | Caspase 7 inhibitor | 0.079 0.065 CID_5282914 | ||
| 0.105 | 0.005 | 0.105 | Integrin alpha4 antagonist | |||
| 0.102 | 0.003 | 0.202 | Prostaglandin D2 agonist | 0.202 0.002 CID_5282914 | CID_5282914 | |
| 0.101 | 0.002 | 0.101 | Lysophosphatidic acid receptor 1 agonist | 0.085 0.002 CID_5282914 | ||
| 0.103 | 0.005 | 0.103 | Glucagon-like peptide 1 receptor antagonist | 0.07 0.006 CID_5282914 | ||
| 0.116 | 0.019 | 0.116 | Na+ K+ transporting ATPase inhibitor | 0.114 0.02 CID_5282914 | ||
| 0.117 | 0.019 | 0.117 | Carbonic anhydrase VA inhibitor | 0.066 0.052 CID_5282914 | ||
| 0.102 | 0.005 | 0.102 | GABA B receptor antagonist | 0.067 0.009 CID_5282914 | ||
| 0.103 | 0.005 | 0.103 | Peroxisome proliferator-activated receptor delta agonist | 0.084 0.007 CID_5282914 | ||
| 0.1 | 0.004 | 0.1 | Thyroid hormone alpha antagonist | |||
| 0.113 | 0.018 | 0.113 | D-Ala-D-Ala ligase inhibitor | 0.085 0.054 CID_5282914 | ||
| 0.099 | 0.004 | 0.106 | Lysine carboxypeptidase inhibitor | 0.106 0.004 CID_5282914 | CID_5282914 | |
| 0.098 | 0.004 | 0.098 | Pregnane X receptor antagonist | 0.072 0.012 CID_5282914 | ||
| 0.12 | 0.025 | 0.12 | Macrophage migration inhibitory factor inhibitor | |||
| 0.132 | 0.038 | 0.132 | Carbonic anhydrase XV inhibitor | |||
| 0.13 | 0.036 | 0.13 | Potassium channel (Ca-activated) activator | 0.117 0.043 CID_5282914 | ||
| 0.099 | 0.005 | 0.099 | Purinergic P2T antagonist | 0.023 0.015 CID_5282914 | ||
| 0.111 | 0.017 | 0.116 | Glucagon-like peptide 1 agonist | 0.116 0.015 CID_5282914 | CID_5282914 | |
| 0.101 | 0.007 | 0.104 | Sphingosine kinase inhibitor | 0.104 0.007 CID_5282914 | CID_5282914 | |
| 0.138 | 0.044 | 0.138 | DNA repair enzyme inhibitor | 0.107 0.103 CID_5282914 | ||
| 0.097 | 0.004 | 0.097 | Ryanodine receptor antagonist | 0.068 0.02 CID_5282914 | ||
| 0.096 | 0.003 | 0.096 | Leukotriene C4 antagonist | 0.07 0.004 CID_5282914 | ||
| 0.096 | 0.005 | 0.096 | 5-Alpha-reductase 1 inhibitor | |||
| 0.099 | 0.008 | 0.099 | Cholecystokinin antagonist | |||
| 0.117 | 0.026 | 0.117 | Inducible nitric-oxide synthase inhibitor | |||
| 0.148 | 0.057 | 0.148 | Nav1.6 sodium channel blocker | |||
| 0.117 | 0.026 | 0.117 | Interleukin 5 antagonist | 0.094 0.049 CID_5282914 | ||
| 0.12 | 0.029 | 0.12 | Metalloproteinase-2 inhibitor | 0.079 0.053 CID_5282914 | ||
| 0.091 | 0.002 | 0.103 | Prostaglandin F2 alpha agonist | 0.103 0.001 CID_5282914 | CID_5282914 | |
| 0.157 | 0.068 | 0.157 | Acetylcholine M1 receptor antagonist | 0.116 0.114 CID_5282914 | ||
| 0.093 | 0.004 | 0.093 | AMPA 3 receptor antagonist | |||
| 0.104 | 0.015 | 0.104 | Maillard reaction inhibitor | 0.055 0.038 CID_5282914 | ||
| 0.092 | 0.004 | 0.092 | Geranyltranstransferase inhibitor | 0.061 0.013 CID_5282914 | ||
| 0.093 | 0.005 | 0.093 | AICAR transformylase inhibitor | 0.073 0.009 CID_5282914 | ||
| 0.271 | 0.184 | 0.271 | Calcium channel L-type activator | |||
| 0.108 | 0.021 | 0.108 | Epoxide hydrolase inhibitor | 0.08 0.042 CID_5282914 | ||
| 0.096 | 0.009 | 0.096 | NMDA receptor subunit 3A antagonist | |||
| 0.092 | 0.007 | 0.116 | Adenosine deaminase inhibitor | 0.116 0.004 CID_5282914 | CID_5282914 | |
| 0.103 | 0.017 | 0.103 | Aldose reductase inhibitor | 0.053 0.037 CID_5282914 | ||
| 0.09 | 0.005 | 0.09 | Nicotinic acid receptor agonist | 0.039 0.022 CID_5282914 | ||
| 0.122 | 0.037 | 0.122 | Factor V inhibitor | 0.114 0.045 CID_5282914 | ||
| 0.087 | 0.004 | 0.087 | Kainate receptor 1 antagonist | |||
| 0.088 | 0.005 | 0.088 | Thymidylate synthase inhibitor | 0.06 0.017 CID_5282914 | ||
| 0.245 | 0.162 | 0.314 | Antiobesity | 0.314 0.107 CID_5282914 | CID_5282914 | |
| 0.089 | 0.006 | 0.089 | AMPA 1 receptor antagonist | |||
| 0.086 | 0.004 | 0.086 | GABA uptake inhibitor | 0.065 0.008 CID_5282914 | ||
| 0.177 | 0.095 | 0.192 | Pyruvate kinase inhibitor | 0.192 0.086 CID_5282914 | CID_5282914 | |
| 0.082 | 0.002 | 0.082 | Lysophosphatidic acid receptor 3 agonist | 0.059 0.002 CID_5282914 | ||
| 0.103 | 0.023 | 0.103 | Amidase inhibitor | 0.066 0.054 CID_5282914 | ||
| 0.134 | 0.053 | 0.134 | Beta amyloid protein antagonist | |||
| 0.097 | 0.017 | 0.129 | Neuraminidase inhibitor | 0.129 0.008 CID_5282914 | CID_5282914 | |
| 0.083 | 0.003 | 0.083 | Glutamate (mGluR3) agonist | 0.05 0.005 CID_5282914 | ||
| 0.086 | 0.007 | 0.086 | Urate transporter 1 inhibitor | 0.037 0.03 CID_5282914 | ||
| 0.09 | 0.01 | 0.09 | Diacylglycerol O-acyltransferase inhibitor | 0.047 0.04 CID_5282914 | ||
| 0.083 | 0.004 | 0.083 | Free fatty acid receptor 1 antagonist | 0.04 0.016 CID_5282914 | ||
| 0.084 | 0.005 | 0.084 | Vitronectin receptor antagonist | 0.019 0.017 CID_5282914 | ||
| 0.092 | 0.013 | 0.092 | Carbonic anhydrase XIV inhibitor | 0.052 0.031 CID_5282914 | ||
| 0.087 | 0.008 | 0.087 | Sphingosine 1-phosphate receptor 3 agonist | 0.083 0.008 CID_5282914 | ||
| 0.096 | 0.017 | 0.136 | Neuraminidase (influenza) inhibitor | 0.136 0.009 CID_5282914 | CID_5282914 | |
| 0.112 | 0.033 | 0.112 | ErbB-3 antagonist | 0.093 0.047 CID_5282914 | ||
| 0.141 | 0.062 | 0.141 | Toll-Like receptor antagonist | |||
| 0.079 | 0.002 | 0.081 | Thromboxane agonist | 0.081 0.002 CID_5282914 | CID_5282914 | |
| 0.088 | 0.011 | 0.088 | Cholecystokinin A antagonist | |||
| 0.093 | 0.016 | 0.093 | Acetyl-CoA transferase inhibitor | |||
| 0.11 | 0.033 | 0.11 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.091 0.043 CID_5282914 | ||
| 0.111 | 0.035 | 0.128 | Phosphodiesterase 6D inhibitor | 0.128 0.019 CID_5282914 | CID_5282914 | |
| 0.08 | 0.004 | 0.08 | Glutamate (mGluR8) antagonist | 0.053 0.007 CID_5282914 | ||
| 0.084 | 0.008 | 0.084 | Adenine nucleotide translocase inhibitor | 0.079 0.01 CID_5282914 | ||
| 0.084 | 0.008 | 0.127 | Phosphoglycerate kinase inhibitor | 0.127 0.005 CID_5282914 | CID_5282914 | |
| 0.091 | 0.016 | 0.091 | NMDA 2A receptor antagonist | 0.049 0.038 CID_5282914 | ||
| 0.09 | 0.015 | 0.101 | Exportin-1 inhibitor | 0.101 0.009 CID_5282914 | CID_5282914 | |
| 0.087 | 0.012 | 0.087 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.051 CID_5282914 | ||
| 0.113 | 0.039 | 0.113 | NMDA receptor antagonist | 0.102 0.046 CID_5282914 | ||
| 0.077 | 0.003 | 0.077 | G-protein-coupled receptor 120 agonist | 0.063 0.003 CID_5282914 | ||
| 0.077 | 0.003 | 0.077 | Retinoid X receptor antagonist | 0.048 0.014 CID_5282914 | ||
| 0.1 | 0.027 | 0.1 | Prostaglandin-E synthase inhibitor | |||
| 0.1 | 0.027 | 0.1 | Lipase inhibitor | |||
| 0.112 | 0.041 | 0.112 | Antineoplastic alkaloid | |||
| 0.076 | 0.005 | 0.076 | Peroxisome proliferator-activated receptor alpha antagonist | 0.043 0.009 CID_5282914 | ||
| 0.087 | 0.016 | 0.098 | Nitric oxide donor | 0.098 0.009 CID_5282914 | CID_5282914 | |
| 0.084 | 0.013 | 0.084 | Sphingosine kinase 2 inhibitor | 0.058 0.034 CID_5282914 | ||
| 0.078 | 0.007 | 0.078 | Heparanase inhibitor | 0.061 0.022 CID_5282914 | ||
| 0.09 | 0.02 | 0.09 | Protease 3C (Human rhinovirus) inhibitor | 0.073 0.034 CID_5282914 | ||
| 0.075 | 0.005 | 0.075 | Peptide deformylase inhibitor | 0.028 0.024 CID_5282914 | ||
| 0.135 | 0.066 | 0.135 | NADPH oxidase inhibitor | |||
| 0.08 | 0.011 | 0.08 | HCV NS3/NS4A protease inhibitor | 0.057 0.024 CID_5282914 | ||
| 0.071 | 0.003 | 0.071 | Lysophosphatidic acid 1 receptor antagonist | 0.044 0.004 CID_5282914 | ||
| 0.082 | 0.014 | 0.082 | Glucosylceramidase inhibitor | 0.058 0.034 CID_5282914 | ||
| 0.079 | 0.011 | 0.079 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.093 | 0.025 | 0.093 | Neutrophil collagenase inhibitor | 0.072 0.038 CID_5282914 | ||
| 0.08 | 0.013 | 0.08 | Lipocortins synthesis agonist | 0.064 0.029 CID_5282914 | ||
| 0.075 | 0.008 | 0.075 | VLA-4 antagonist | |||
| 0.079 | 0.013 | 0.079 | Leukocyte elastase inhibitor | |||
| 0.071 | 0.005 | 0.071 | Guanylate cyclase inhibitor | 0.06 0.011 CID_5282914 | ||
| 0.073 | 0.007 | 0.073 | Caspase 2 inhibitor | 0.056 0.01 CID_5282914 | ||
| 0.073 | 0.008 | 0.073 | AMPA 2 receptor antagonist | |||
| 0.069 | 0.005 | 0.069 | Kynurenine 3 monooxygenase inhibitor | 0.065 0.005 CID_5282914 | ||
| 0.069 | 0.005 | 0.069 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.047 0.019 CID_5282914 | ||
| 0.1 | 0.036 | 0.1 | Chymotrypsin inhibitor | |||
| 0.085 | 0.02 | 0.085 | Beta 3 adrenoreceptor antagonist | 0.077 0.026 CID_5282914 | ||
| 0.072 | 0.008 | 0.072 | Dihydropteroate synthase inhibitor | 0.035 0.034 CID_5282914 | ||
| 0.11 | 0.046 | 0.11 | Nitric-oxide synthase inhibitor | |||
| 0.067 | 0.004 | 0.067 | Retinoid X gamma receptor agonist | 0.023 0.017 CID_5282914 | ||
| 0.067 | 0.005 | 0.067 | Integrin beta3 antagonist | 0.018 0.016 CID_5282914 | ||
| 0.071 | 0.009 | 0.071 | Squalene synthetase inhibitor | 0.067 0.01 CID_5282914 | ||
| 0.119 | 0.058 | 0.119 | Estrogen antagonist | |||
| 0.069 | 0.008 | 0.07 | Cytokine production stimulant | 0.07 0.007 CID_5282914 | CID_5282914 | |
| 0.062 | 0.002 | 0.064 | Thromboxane A2 agonist | 0.064 0.002 CID_5282914 | CID_5282914 | |
| 0.065 | 0.005 | 0.065 | VCAM-1 antagonist | 0.042 0.019 CID_5282914 | ||
| 0.065 | 0.005 | 0.065 | VCAM antagonist | 0.042 0.019 CID_5282914 | ||
| 0.069 | 0.009 | 0.069 | Dopamine D5 agonist | |||
| 0.076 | 0.016 | 0.076 | Angiotensin-converting enzyme inhibitor | 0.076 0.015 CID_5282914 | ||
| 0.064 | 0.003 | 0.064 | Retinoid X alpha receptor antagonist | 0.039 0.016 CID_5282914 | ||
| 0.082 | 0.023 | 0.082 | Androgen agonist | |||
| 0.063 | 0.003 | 0.063 | Ileal bile acid transport inhibitor | 0.034 0.004 CID_5282914 | ||
| 0.064 | 0.005 | 0.064 | Angiotensin AT1 receptor antagonist | 0.048 0.02 CID_5282914 | ||
| 0.064 | 0.004 | 0.064 | Integrin alphaVbeta3 antagonist | 0.027 0.01 CID_5282914 | ||
| 0.074 | 0.014 | 0.074 | DNA helicase inhibitor | 0.051 0.045 CID_5282914 | ||
| 0.086 | 0.027 | 0.086 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.063 | 0.004 | 0.063 | Angiotensin II receptor antagonist | 0.038 0.017 CID_5282914 | ||
| 0.083 | 0.025 | 0.1 | Beta adrenoreceptor antagonist | 0.1 0.016 CID_5282914 | CID_5282914 | |
| 0.078 | 0.021 | 0.078 | Matrix metalloproteinase (membrane-type) inhibitor | 0.057 0.036 CID_5282914 | ||
| 0.062 | 0.005 | 0.062 | Uridine phosphorylase inhibitor | 0.054 0.007 CID_5282914 | ||
| 0.075 | 0.018 | 0.082 | Bombesin 2 receptor antagonist | 0.082 0.017 CID_5282914 | CID_5282914 | |
| 0.066 | 0.009 | 0.067 | Neuraminidase (Influenza A) inhibitor | 0.067 0.009 CID_5282914 | CID_5282914 | |
| 0.088 | 0.032 | 0.088 | Matrix metalloproteinase inhibitor | |||
| 0.07 | 0.014 | 0.07 | Squalene epoxidase inhibitor | |||
| 0.06 | 0.004 | 0.06 | Thyroid hormone agonist | 0.032 0.01 CID_5282914 | ||
| 0.06 | 0.004 | 0.06 | Epoxide hydrolase 1 inhibitor | |||
| 0.069 | 0.013 | 0.081 | Calcitonin receptor agonist | 0.081 0.012 CID_5282914 | CID_5282914 | |
| 0.09 | 0.035 | 0.09 | Estrogen receptor alpha antagonist | |||
| 0.092 | 0.037 | 0.092 | Metalloproteinase-9 inhibitor | 0.072 0.052 CID_5282914 | ||
| 0.075 | 0.021 | 0.075 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.057 | 0.002 | 0.057 | Vanilloid 2 agonist | 0.034 0.006 CID_5282914 | ||
| 0.098 | 0.043 | 0.126 | ATPase (Vacuolar H+) inhibitor | 0.126 0.016 CID_5282914 | CID_5282914 | |
| 0.075 | 0.02 | 0.075 | Autotaxin inhibitor | |||
| 0.072 | 0.018 | 0.072 | Metalloproteinase-3 inhibitor | 0.045 0.04 CID_5282914 | ||
| 0.203 | 0.148 | 0.203 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.059 | 0.005 | 0.08 | HMG CoA reductase inhibitor | 0.08 0.003 CID_5282914 | CID_5282914 | |
| 0.059 | 0.005 | 0.059 | Vanilloid 3 antagonist | 0.043 0.016 CID_5282914 | ||
| 0.058 | 0.005 | 0.058 | Integrin alpha1beta1 antagonist | 0.043 0.015 CID_5282914 | ||
| 0.059 | 0.005 | 0.059 | Kainate receptor 4 antagonist | |||
| 0.057 | 0.003 | 0.057 | Calcium-independent phospholipase A2 inhibitor | 0.048 0.004 CID_5282914 | ||
| 0.169 | 0.115 | 0.169 | Histone acetyltransferase inhibitor | |||
| 0.062 | 0.009 | 0.062 | Dihydrofolate reductase inhibitor | |||
| 0.075 | 0.022 | 0.075 | Fatty acid synthase inhibitor | |||
| 0.061 | 0.009 | 0.062 | p53 inhibitor | 0.062 0.008 CID_5282914 | CID_5282914 | |
| 0.074 | 0.022 | 0.087 | Beta 1 adrenoreceptor antagonist | 0.087 0.014 CID_5282914 | CID_5282914 | |
| 0.056 | 0.004 | 0.056 | Leukotriene B4 receptor 2 antagonist | 0.052 0.004 CID_5282914 | ||
| 0.084 | 0.032 | 0.084 | Sirtuin 1 inhibitor | 0.081 0.035 CID_5282914 | ||
| 0.117 | 0.065 | 0.117 | Transcription factor STAT6 inhibitor | |||
| 0.061 | 0.009 | 0.064 | Sphingosine kinase 1 inhibitor | 0.064 0.008 CID_5282914 | CID_5282914 | |
| 0.054 | 0.002 | 0.054 | Retinoid X beta receptor antagonist | 0.027 0.005 CID_5282914 | ||
| 0.06 | 0.009 | 0.06 | Cholecystokinin B antagonist | |||
| 0.067 | 0.016 | 0.067 | Vanilloid 2 antagonist | 0.054 0.031 CID_5282914 | ||
| 0.108 | 0.058 | 0.108 | Urease inhibitor | |||
| 0.067 | 0.017 | 0.067 | Oleamide hydrolase inhibitor | |||
| 0.108 | 0.058 | 0.146 | Protease inhibitor | 0.146 0.032 CID_5282914 | CID_5282914 | |
| 0.053 | 0.003 | 0.053 | Prostaglandin H2 antagonist | 0.045 0.004 CID_5282914 | ||
| 0.064 | 0.015 | 0.064 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.126 | 0.077 | 0.126 | Nav1.2 sodium channel blocker | 0.125 0.078 CID_5282914 | ||
| 0.056 | 0.007 | 0.056 | Liver X receptor beta antagonist | |||
| 0.053 | 0.005 | 0.053 | Retinoid X beta receptor agonist | 0.019 0.018 CID_5282914 | ||
| 0.123 | 0.075 | 0.123 | M17 leucyl aminopeptidase inhibitor | |||
| 0.097 | 0.049 | 0.097 | Histamine N-methyltransferase inhibitor | |||
| 0.097 | 0.049 | 0.123 | Androgen antagonist | 0.123 0.032 CID_5282914 | CID_5282914 | |
| 0.062 | 0.015 | 0.062 | Oxytocin agonist | |||
| 0.091 | 0.044 | 0.091 | Glutamate receptor agonist | |||
| 0.054 | 0.007 | 0.054 | Cholecystokinin agonist | |||
| 0.084 | 0.037 | 0.084 | MAP kinase kinase 7 inhibitor | 0.074 0.065 CID_5282914 | ||
| 0.052 | 0.006 | 0.052 | Carboxypeptidase B inhibitor | 0.047 0.008 CID_5282914 | ||
| 0.075 | 0.028 | 0.075 | Collagenase 3 inhibitor | |||
| 0.055 | 0.009 | 0.055 | Angiotensin AT2 receptor antagonist | |||
| 0.062 | 0.016 | 0.062 | Cholesterol esterase inhibitor | 0.046 0.036 CID_5282914 | ||
| 0.065 | 0.02 | 0.065 | Beta 2 adrenoreceptor antagonist | 0.06 0.024 CID_5282914 | ||
| 0.062 | 0.017 | 0.062 | Glutamate (mGluR group III) agonist | |||
| 0.048 | 0.004 | 0.048 | Nicotinic acid receptor 2 antagonist | |||
| 0.049 | 0.005 | 0.049 | Kainate receptor 5 antagonist | |||
| 0.051 | 0.006 | 0.051 | Ceramide glucosyltransferase inhibitor | |||
| 0.06 | 0.016 | 0.06 | Dihydroorotase inhibitor | |||
| 0.046 | 0.002 | 0.046 | Glutamate (mGluR6) agonist | 0.026 0.003 CID_5282914 | ||
| 0.095 | 0.051 | 0.095 | Aminoacyl-tRNA synthetase inhibitor | 0.088 0.062 CID_5282914 | ||
| 0.051 | 0.008 | 0.051 | Carnitine palmitoyltransferase inhibitor | |||
| 0.087 | 0.044 | 0.087 | CC chemokine 5 receptor agonist | |||
| 0.057 | 0.014 | 0.068 | G protein-coupled receptor agonist | 0.068 0.01 CID_5282914 | CID_5282914 | |
| 0.172 | 0.129 | 0.172 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.063 | 0.02 | 0.063 | Carbonic anhydrase II stimulant | |||
| 0.056 | 0.014 | 0.056 | Integrin alpha5beta1 antagonist | 0.037 0.035 CID_5282914 | ||
| 0.074 | 0.032 | 0.074 | Cannabinoid CB1 receptor agonist | |||
| 0.057 | 0.015 | 0.057 | Thymidine kinase inhibitor | 0.05 0.019 CID_5282914 | ||
| 0.053 | 0.012 | 0.053 | Retinoic acid alpha receptor agonist | |||
| 0.053 | 0.013 | 0.059 | Farnesoid X receptor agonist | 0.059 0.01 CID_5282914 | CID_5282914 | |
| 0.048 | 0.009 | 0.048 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.044 | 0.005 | 0.044 | Integrin alphaVbeta1 antagonist | 0.02 0.011 CID_5282914 | ||
| 0.044 | 0.005 | 0.044 | Purinergic P2Y15 antagonist | 0.031 0.015 CID_5282914 | ||
| 0.048 | 0.009 | 0.048 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.047 0.01 CID_5282914 | ||
| 0.116 | 0.078 | 0.116 | Nav1.3 sodium channel blocker | |||
| 0.042 | 0.004 | 0.042 | Hedgehog signaling activator | 0.033 0.008 CID_5282914 | ||
| 0.152 | 0.114 | 0.206 | P-glycoprotein inhibitor | 0.206 0.06 CID_5282914 | CID_5282914 | |
| 0.179 | 0.141 | 0.36 | Cardiotonic | 0.36 0.037 CID_5282914 | CID_5282914 | |
| 0.04 | 0.002 | 0.04 | Carbonic anhydrase XI inhibitor | 0.025 0.003 CID_5282914 | ||
| 0.045 | 0.008 | 0.048 | Methionyl aminopeptidase 1 inhibitor | 0.048 0.007 CID_5282914 | CID_5282914 | |
| 0.043 | 0.007 | 0.043 | Elastase 2B inhibitor | |||
| 0.043 | 0.007 | 0.043 | Elastase 3A inhibitor | |||
| 0.043 | 0.007 | 0.043 | Elastase 3B inhibitor | |||
| 0.1 | 0.064 | 0.157 | Bronchodilator | 0.157 0.029 CID_5282914 | CID_5282914 | |
| 0.041 | 0.004 | 0.041 | Aminopeptidase A inhibitor | 0.036 0.005 CID_5282914 | ||
| 0.059 | 0.022 | 0.059 | Complement C3a chemotactic receptor antagonist | 0.052 0.025 CID_5282914 | ||
| 0.055 | 0.019 | 0.055 | Erythropoietin receptor agonist | |||
| 0.056 | 0.021 | 0.056 | Adenylate cyclase 1 inhibitor | 0.054 0.023 CID_5282914 | ||
| 0.04 | 0.005 | 0.04 | Retinoid X gamma receptor antagonist | 0.028 0.017 CID_5282914 | ||
| 0.055 | 0.021 | 0.055 | Dopamine beta hydroxylase inhibitor | |||
| 0.044 | 0.01 | 0.044 | Tryptophan 5 hydroxylase inhibitor | 0.037 0.022 CID_5282914 | ||
| 0.059 | 0.026 | 0.062 | Immunoglobulin Fc receptor antagonist | 0.062 0.021 CID_5282914 | CID_5282914 | |
| 0.05 | 0.017 | 0.05 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.037 | 0.004 | 0.037 | Isoleucine-tRNA ligase inhibitor | 0.033 0.004 CID_5282914 | ||
| 0.036 | 0.004 | 0.038 | Neuraminidase (Influenza B) inhibitor | 0.038 0.003 CID_5282914 | CID_5282914 | |
| 0.067 | 0.034 | 0.067 | Xanthine dehydrogenase inhibitor | |||
| 0.059 | 0.026 | 0.059 | Prolyl endopeptidase inhibitor | |||
| 0.054 | 0.022 | 0.054 | Carbonic anhydrase IV inhibitor | |||
| 0.066 | 0.034 | 0.066 | Aminopeptidase microsomal inhibitor | |||
| 0.057 | 0.026 | 0.073 | Endothelin-converting enzyme inhibitor | 0.073 0.02 CID_5282914 | CID_5282914 | |
| 0.067 | 0.035 | 0.07 | Calcium channel P-type blocker | 0.07 0.028 CID_5282914 | CID_5282914 | |
| 0.068 | 0.037 | 0.068 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.059 | 0.028 | 0.059 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.053 | 0.022 | 0.053 | Benzodiazepine antagonist | |||
| 0.057 | 0.026 | 0.057 | AMPA receptor antagonist | |||
| 0.06 | 0.029 | 0.06 | Dihydroorotate oxidase inhibitor | |||
| 0.064 | 0.034 | 0.064 | Beta 2 adrenoreceptor agonist | 0.061 0.046 CID_5282914 | ||
| 0.076 | 0.046 | 0.076 | Potassium channel (Tandem pore domain) blocker | |||
| 0.086 | 0.055 | 0.086 | mTOR complex 2 inhibitor | |||
| 0.042 | 0.012 | 0.042 | Endothelin receptor antagonist | |||
| 0.039 | 0.009 | 0.039 | Caspase 6 inhibitor | 0.031 0.019 CID_5282914 | ||
| 0.034 | 0.004 | 0.034 | Caspase 8 inhibitor | 0.026 0.007 CID_5282914 | ||
| 0.039 | 0.009 | 0.039 | Neutral endopeptidase inhibitor | 0.018 0.017 CID_5282914 | ||
| 0.045 | 0.015 | 0.045 | Integrin alpha2 antagonist | |||
| 0.083 | 0.054 | 0.083 | Thioredoxin reductase inhibitor | |||
| 0.041 | 0.012 | 0.041 | Diacylglycerol O-acyltransferase 1 inhibitor | |||
| 0.102 | 0.073 | 0.102 | Protein kinase C gamma inhibitor | |||
| 0.049 | 0.021 | 0.049 | Guanylate cyclase stimulant | 0.047 0.024 CID_5282914 | ||
| 0.076 | 0.048 | 0.076 | Adenosine A3 receptor antagonist | |||
| 0.032 | 0.004 | 0.041 | Vitamin D receptor agonist | 0.041 0.003 CID_5282914 | CID_5282914 | |
| 0.033 | 0.005 | 0.033 | Kainate receptor 3 antagonist | |||
| 0.042 | 0.014 | 0.042 | Glutamate (mGluR4) agonist | |||
| 0.081 | 0.053 | 0.081 | Acetylcholine nicotinic antagonist | |||
| 0.055 | 0.028 | 0.062 | Phosphorylase inhibitor | 0.062 0.024 CID_5282914 | CID_5282914 | |
| 0.034 | 0.008 | 0.042 | Toll-Like receptor 4 agonist | 0.042 0.004 CID_5282914 | CID_5282914 | |
| 0.034 | 0.007 | 0.034 | Integrin beta5 antagonist | 0.02 0.015 CID_5282914 | ||
| 0.058 | 0.032 | 0.059 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.059 0.031 CID_5282914 | CID_5282914 | |
| 0.14 | 0.114 | 0.14 | Tumour necrosis factor antagonist | |||
| 0.072 | 0.046 | 0.072 | HIV-1 integrase inhibitor | |||
| 0.029 | 0.003 | 0.03 | Methylmalonyl-CoA mutase inhibitor | 0.03 0.002 CID_5282914 | CID_5282914 | |
| 0.035 | 0.009 | 0.039 | Prostaglandin EP1 antagonist | 0.039 0.008 CID_5282914 | CID_5282914 | |
| 0.046 | 0.02 | 0.046 | Heme oxygenase inhibitor | 0.045 0.024 CID_5282914 | ||
| 0.03 | 0.005 | 0.03 | Retinoic acid beta receptor agonist | |||
| 0.044 | 0.019 | 0.044 | MAP3K5 inhibitor | |||
| 0.03 | 0.005 | 0.03 | Cholecystokinin A agonist | |||
| 0.038 | 0.014 | 0.054 | Cholesterol ester transfer protein antagonist | 0.054 0.005 CID_5282914 | CID_5282914 | |
| 0.06 | 0.037 | 0.063 | Botulinum neurotoxin type A inhibitor | 0.063 0.033 CID_5282914 | CID_5282914 | |
| 0.032 | 0.009 | 0.032 | Retinoic acid receptor agonist | |||
| 0.034 | 0.011 | 0.037 | LFA antagonist | 0.037 0.01 CID_5282914 | CID_5282914 | |
| 0.065 | 0.042 | 0.065 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.026 | 0.004 | 0.026 | Telomerase stimulant | 0.021 0.007 CID_5282914 | ||
| 0.027 | 0.004 | 0.027 | Angiotensin AT1B receptor antagonist | |||
| 0.046 | 0.024 | 0.046 | Nerve growth factor antagonist | |||
| 0.05 | 0.028 | 0.05 | Neurotensin receptor antagonist | |||
| 0.051 | 0.028 | 0.051 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.045 | 0.023 | 0.045 | Plasmepsin II inhibitor | |||
| 0.079 | 0.058 | 0.094 | Adrenaline agonist | 0.094 0.042 CID_5282914 | CID_5282914 | |
| 0.056 | 0.035 | 0.056 | Epithelial sodium channel blocker | |||
| 0.03 | 0.009 | 0.03 | Elastase 2 inhibitor | |||
| 0.03 | 0.009 | 0.03 | Elastase 2A inhibitor | |||
| 0.026 | 0.006 | 0.026 | Toll-Like receptor 8 agonist | 0.02 0.015 CID_5282914 | ||
| 0.053 | 0.032 | 0.053 | CXC chemokine 1 receptor antagonist | |||
| 0.03 | 0.009 | 0.03 | Acid ceramidase inhibitor | |||
| 0.06 | 0.04 | 0.075 | Cathepsin E inhibitor | 0.075 0.025 CID_5282914 | CID_5282914 | |
| 0.032 | 0.012 | 0.032 | Estrogen-related receptor gamma antagonist | |||
| 0.049 | 0.03 | 0.051 | Aldosterone antagonist | 0.051 0.028 CID_5282914 | CID_5282914 | |
| 0.028 | 0.008 | 0.028 | Retinoic acid gamma receptor agonist | |||
| 0.037 | 0.018 | 0.037 | Adenosine uptake inhibitor | |||
| 0.052 | 0.032 | 0.052 | Potassium channel (Inward rectifier) activator | |||
| 0.024 | 0.005 | 0.024 | Thyroid hormone alpha agonist | |||
| 0.024 | 0.005 | 0.024 | Nicotinic acid receptor 1 antagonist | |||
| 0.044 | 0.025 | 0.044 | Neurokinin 2 agonist | |||
| 0.038 | 0.02 | 0.038 | RNA-directed RNA polymerase inhibitor | |||
| 0.022 | 0.004 | 0.022 | Integrin beta6 antagonist | 0.016 0.007 CID_5282914 | ||
| 0.049 | 0.031 | 0.049 | Potassium channel (ATP-sensitive) activator | |||
| 0.028 | 0.01 | 0.028 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.031 | 0.014 | 0.031 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.027 | 0.01 | 0.027 | Integrin alpha4beta7 antagonist | |||
| 0.066 | 0.049 | 0.066 | Potassium channel large-conductance Ca-activated activator | |||
| 0.073 | 0.056 | 0.073 | CYP2A6 inhibitor | |||
| 0.041 | 0.024 | 0.041 | Glutamate (mGluR group II) antagonist | |||
| 0.073 | 0.057 | 0.073 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.08 | 0.064 | 0.08 | T cell inhibitor | 0.08 0.065 CID_5282914 | ||
| 0.025 | 0.009 | 0.025 | Angiotensin AT1A receptor antagonist | |||
| 0.048 | 0.032 | 0.048 | Potassium channel Kv1.3 blocker | |||
| 0.02 | 0.004 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.022 | 0.007 | 0.026 | Antibiotic Anthracycline-like | 0.026 0.005 CID_5282914 | CID_5282914 | |
| 0.125 | 0.11 | 0.125 | Neuropeptide Y1 antagonist | |||
| 0.035 | 0.02 | 0.035 | HCV polyprotein inhibitor | |||
| 0.037 | 0.023 | 0.037 | Nicotinic acid receptor 2 agonist | |||
| 0.102 | 0.088 | 0.102 | Acetylcholine muscarinic antagonist | |||
| 0.038 | 0.024 | 0.038 | Delayed rectifier potassium channel blocker | |||
| 0.048 | 0.034 | 0.048 | Aminopeptidase N inhibitor | |||
| 0.03 | 0.016 | 0.03 | NMDA 2D receptor antagonist | |||
| 0.02 | 0.007 | 0.02 | Purinergic P2Y1 agonist | 0.015 0.012 CID_5282914 | ||
| 0.022 | 0.008 | 0.022 | Estrogen-related receptor gamma agonist | |||
| 0.029 | 0.015 | 0.029 | Glucosylceramidase stimulant | |||
| 0.04 | 0.027 | 0.04 | Aggrecanase 1 inhibitor | |||
| 0.038 | 0.025 | 0.038 | Factor XIIIa inhibitor | |||
| 0.045 | 0.032 | 0.049 | Beta adrenoreceptor agonist | 0.049 0.02 CID_5282914 | CID_5282914 | |
| 0.037 | 0.025 | 0.037 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.028 | 0.016 | 0.028 | Calcium-sensing receptor agonist | |||
| 0.024 | 0.013 | 0.024 | Endothelin A receptor antagonist | |||
| 0.027 | 0.016 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.018 CID_5282914 | ||
| 0.015 | 0.005 | 0.015 | Carboxypeptidase B2 inhibitor | 0.012 0.007 CID_5282914 | ||
| 0.033 | 0.023 | 0.033 | Melatonin receptor 1A agonist | |||
| 0.017 | 0.007 | 0.017 | Integrin alphaVbeta6 antagonist | 0.015 0.009 CID_5282914 | ||
| 0.014 | 0.004 | 0.014 | Thyroid hormone beta agonist | |||
| 0.021 | 0.012 | 0.021 | Endothelin B receptor antagonist | |||
| 0.041 | 0.032 | 0.041 | Histamine H2 receptor agonist | |||
| 0.036 | 0.026 | 0.036 | Histone deacetylase 7 inhibitor | |||
| 0.028 | 0.018 | 0.028 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.051 | 0.042 | 0.051 | GABA receptor antagonist | |||
| 0.091 | 0.082 | 0.091 | Estrogen receptor beta antagonist | |||
| 0.037 | 0.028 | 0.037 | DNA gyrase subunit B inhibitor | |||
| 0.047 | 0.039 | 0.047 | Collagenase inhibitor | |||
| 0.012 | 0.003 | 0.012 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.008 0.004 CID_5282914 | ||
| 0.019 | 0.01 | 0.019 | Integrin alpha4beta1 antagonist | |||
| 0.028 | 0.02 | 0.028 | 1,3-Beta-glucan synthase inhibitor | |||
| 0.021 | 0.013 | 0.021 | Retinoic acid alpha receptor antagonist | |||
| 0.011 | 0.003 | 0.011 | Integrin alpha5beta6 antagonist | 0.007 0.004 CID_5282914 | ||
| 0.029 | 0.021 | 0.029 | Liver X receptor alpha antagonist | |||
| 0.013 | 0.005 | 0.013 | Angiotensin AT2 receptor agonist | |||
| 0.021 | 0.014 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.016 CID_5282914 | ||
| 0.019 | 0.012 | 0.019 | Retinoic acid receptor antagonist | |||
| 0.031 | 0.024 | 0.031 | Sirtuin 2 inhibitor | |||
| 0.016 | 0.009 | 0.016 | Egl nine homolog 1 inhibitor | |||
| 0.018 | 0.012 | 0.018 | CXC chemokine 5 receptor antagonist | |||
| 0.034 | 0.027 | 0.034 | Growth factor receptor-bound protein 2 antagonist | |||
| 0.039 | 0.032 | 0.039 | Liver X receptor alpha agonist | |||
| 0.059 | 0.052 | 0.059 | Phosphodiesterase 1C inhibitor | |||
| 0.064 | 0.058 | 0.064 | NMDA 2 receptor antagonist | |||
| 0.041 | 0.034 | 0.041 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.012 | 0.006 | 0.012 | Integrin alphaVbeta5 antagonist | |||
| 0.02 | 0.014 | 0.02 | Integrin beta7 antagonist | |||
| 0.022 | 0.016 | 0.034 | Vitamin D receptor antagonist | 0.034 0.006 CID_5282914 | CID_5282914 | |
| 0.025 | 0.02 | 0.025 | Integrin alpha2beta1 antagonist | |||
| 0.031 | 0.026 | 0.031 | Liver X receptor beta agonist | |||
| 0.029 | 0.024 | 0.029 | Liver X receptor antagonist | |||
| 0.035 | 0.03 | 0.035 | Carbonic anhydrase I stimulant | |||
| 0.029 | 0.024 | 0.029 | HCV NS5B polymerase inhibitor | |||
| 0.022 | 0.018 | 0.022 | ICAM 1 antagonist | |||
| 0.03 | 0.026 | 0.03 | Dipeptidyl peptidase II inhibitor | |||
| 0.025 | 0.021 | 0.025 | Thymidine phosphorylase inhibitor | |||
| 0.1 | 0.096 | 0.1 | Cholinergic antagonist | |||
| 0.042 | 0.038 | 0.053 | Microtubule stabilization | 0.053 0.023 CID_5282914 | CID_5282914 | |
| 0.049 | 0.044 | 0.049 | Human rhinovirus A protease inhibitor | |||
| 0.037 | 0.032 | 0.037 | Histone deacetylase 9 inhibitor | |||
| 0.025 | 0.021 | 0.025 | Urotensin II agonist | |||
| 0.008 | 0.005 | 0.008 | Free fatty acid receptor 2 antagonist | |||
| 0.056 | 0.053 | 0.056 | Transcription factor AP-1 inhibitor | |||
| 0.024 | 0.021 | 0.024 | Complement factor 1s inhibitor | |||
| 0.064 | 0.061 | 0.064 | Calcium channel L-type blocker | |||
| 0.169 | 0.167 | 0.169 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.058 | 0.056 | 0.058 | Histone deacetylase SIRT3 inhibitor | |||
| 0.036 | 0.035 | 0.036 | Glutamate (mGluR1a) antagonist | |||
| 0.014 | 0.012 | 0.014 | Adenosine A2a receptor agonist | |||
| 0.044 | 0.043 | 0.044 | Matrix metalloproteinase 1 inhibitor | |||
| 0.005 | 0.004 | 0.005 | Bone morphogenic protein 1 inhibitor | |||
| 0.019 | 0.018 | 0.019 | Corticosteroid-like | |||
| 0.006 | 0.007 | 0.017 | DNA polymerase III subunit alpha inhibitor | 0.017 0.002 CID_5282914 | CID_5282914 | |
| 0.063 | 0.066 | 0.076 | Secretase beta inhibitor | 0.076 0.041 CID_5282914 | CID_5282914 | |
| 0.106 | 0.113 | 0.219 | Interleukin 1 antagonist | 0.219 0.026 CID_5282914 | CID_5282914 | |
| 0.02 | 0.03 | 0.027 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.027 0.02 CID_5282914 | CID_5282914 | |
| 0.024 | 0.035 | 0.036 | DNA polymerase III inhibitor | 0.036 0.007 CID_5282914 | CID_5282914 | |
| 0.041 | 0.052 | 0.05 | Protein 50S ribosomal subunit inhibitor | 0.05 0.04 CID_5282914 | CID_5282914 | |
| 0.082 | 0.095 | 0.104 | Nav1.1 sodium channel blocker | 0.104 0.061 CID_5282914 | CID_5282914 | |
| 0.01 | 0.023 | 0.015 | Calcium-sensing receptor antagonist | 0.015 0.011 CID_5282914 | CID_5282914 | |
| 0.059 | 0.073 | 0.152 | Antineoplastic antibiotic | 0.152 0.03 CID_5282914 | CID_5282914 | |
| 0.022 | 0.036 | 0.039 | Plasmepsin I inhibitor | 0.039 0.013 CID_5282914 | CID_5282914 | |
| 0.003 | 0.025 | 0.011 | Mannitol 2-dehydrogenase inhibitor | 0.011 0.004 CID_5282914 | CID_5282914 | |
| 0.01 | 0.035 | 0.015 | DNA polymerase III polC-type inhibitor | 0.015 0.005 CID_5282914 | CID_5282914 | |
| 0.013 | 0.042 | 0.022 | Aminopeptidase P inhibitor | 0.022 0.017 CID_5282914 | CID_5282914 | |
| 0.038 | 0.067 | 0.081 | Cathepsin D inhibitor | 0.081 0.025 CID_5282914 | CID_5282914 | |
| 0.093 | 0.131 | 0.11 | Sphingosine 1-phosphate receptor 2 agonist | 0.11 0.075 CID_5282914 | CID_5282914 | |
| 0.024 | 0.074 | 0.042 | Growth hormone release inhibitor | 0.042 0.029 CID_5282914 | CID_5282914 | |
| 0.024 | 0.077 | 0.052 | HIV-1 protease inhibitor | 0.052 0.019 CID_5282914 | CID_5282914 | |
| 0.073 | 0.131 | 0.204 | Interleukin 1b antagonist | 0.204 0.019 CID_5282914 | CID_5282914 | |
| 0.026 | 0.086 | 0.115 | Neuropeptide agonist | 0.115 0.023 CID_5282914 | CID_5282914 | |
| 0.01 | 0.085 | 0.051 | Renin inhibitor | 0.051 0.017 CID_5282914 | CID_5282914 | |
| 0.112 | 0.214 | 0.374 | Tumour necrosis factor alpha release inhibitor | 0.374 0.032 CID_5282914 | CID_5282914 | |
| 0.058 | 0.207 | 0.083 | 3C-Like protease (SARS coronavirus) inhibitor | 0.083 0.06 CID_5282914 | CID_5282914 | |
| 0.035 | 0.204 | 0.073 | Somatostatin 1 agonist | 0.073 0.061 CID_5282914 | CID_5282914 | |
| 0.083 | 0.274 | 0.15 | Papain-like protease (SARS coronavirus) inhibitor | 0.15 0.033 CID_5282914 | CID_5282914 | |
| 0.09 | 0.339 | 0.156 | Growth factor agonist | 0.156 0.129 CID_5282914 | CID_5282914 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |